npj Parkinson s Disease,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: May 5, 2025
While
conventional
deep
brain
stimulation
(cDBS)
treatment
delivers
continuous
electrical
stimuli,
new
adaptive
DBS
(aDBS)
technology
provides
dynamic
symptom-related
stimulation.
Research
data
are
promising,
and
devices
already
available,
but
we
ready
for
it?
We
asked
leading
experts
worldwide
(n
=
21)
to
discuss
a
research
agenda
aDBS
in
the
near
future
allow
full
adoption.
A
5-point
Likert
scale
questionnaire,
along
with
Delphi
method,
was
employed.
In
next
10
years,
will
be
clinical
routine,
is
needed
define
which
patients
would
benefit
more
from
treatment;
second,
implantation
programming
procedures
should
simplified
actual
generalized
adoption;
third,
algorithms,
integration
of
paradigm
technologies,
improve
control
complex
symptoms.
Since
years
crucial
implementation,
focus
on
improving
precision
making
accessible.
Frontiers in Neurology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 9, 2022
Deep
brain
stimulation
(DBS)
has
advanced
treatment
options
for
a
variety
of
neurologic
and
neuropsychiatric
conditions.
As
the
technology
DBS
continues
to
progress,
efficacy
will
continue
improve
disease
indications
expand.
Hardware
advances
such
as
longer-lasting
batteries
reduce
frequency
battery
replacement
segmented
leads
facilitate
improvements
in
effectiveness
have
potential
minimize
side
effects.
Targeting
specialized
imaging
sequences
“connectomics”
improved
accuracy
lead
positioning
trajectory
planning.
Software
closed-loop
remote
programming
enable
be
more
personalized
accessible
technology.
The
future
promising
holds
further
quality
life.
In
this
review
we
address
past,
present
DBS.
National Science Review,
Journal Year:
2024,
Volume and Issue:
11(5)
Published: Feb. 27, 2024
ABSTRACT
Virtual
brain
twins
are
personalized,
generative
and
adaptive
models
based
on
data
from
an
individual’s
for
scientific
clinical
use.
After
a
description
of
the
key
elements
virtual
twins,
we
present
standard
model
personalized
whole-brain
network
models.
The
personalization
is
accomplished
using
subject’s
imaging
by
three
means:
(1)
assemble
cortical
subcortical
areas
in
subject-specific
space;
(2)
directly
map
connectivity
into
models,
which
can
be
generalized
to
other
parameters;
(3)
estimate
relevant
parameters
through
inversion,
typically
probabilistic
machine
learning.
We
use
healthy
ageing
five
diseases:
epilepsy,
Alzheimer’s
disease,
multiple
sclerosis,
Parkinson’s
disease
psychiatric
disorders.
Specifically,
introduce
spatial
masks
demonstrate
their
physiological
pathophysiological
hypotheses.
Finally,
pinpoint
challenges
future
directions.
npj Digital Medicine,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: Jan. 4, 2025
Abstract
Adaptive
deep
brain
stimulation
(DBS)
provides
individualized
therapy
for
people
with
Parkinson’s
disease
(PWP)
by
adjusting
the
in
real-time
using
neural
signals
that
reflect
their
motor
state.
Current
algorithms,
however,
utilize
condensed
and
manually
selected
features
which
may
result
a
less
robust
biased
therapy.
In
this
study,
we
propose
Neural-to-Gait
Neural
network
(N2GNet),
novel
learning-based
regression
model
capable
of
tracking
gait
performance
from
subthalamic
nucleus
local
field
potentials
(STN
LFPs).
The
LFP
data
were
acquired
when
eighteen
PWP
performed
stepping
place,
ground
reaction
forces
measured
to
track
weight
shifts
representing
performance.
By
exhibiting
stronger
correlation
compared
higher-correlation
beta
power
two
leads
outperforming
other
evaluated
designs,
N2GNet
effectively
leverages
comprehensive
frequency
band,
not
limited
range,
solely
STN
LFPs.
Journal of the Neurological Sciences,
Journal Year:
2022,
Volume and Issue:
435, P. 120196 - 120196
Published: Feb. 19, 2022
Tremor
is
one
of
the
primary
motor
symptoms
Parkinson's
disease
(PD),
and
it
characterized
by
a
highly
phenomenological
heterogeneity.
Clinical
experimental
observations
suggest
that
tremor
in
PD
cannot
be
interpreted
merely
as
an
expression
dopaminergic
denervation
basal
ganglia.
Accordingly,
other
neurotransmitter
systems
brain
areas
are
involved.
We
here
review
neurochemical,
neurophysiological,
neuroimaging
data
basis
presence
dysfunctional
network
underlying
PD.
will
discuss
role
altered
oscillations
synchronization
two
partially
overlapping
central
circuitries,
e.g.,
cerebello-thalamo-cortical
ganglia-cortical
loops.
also
emphasize
pathophysiological
consequences
abnormal
interplay
between
systems.
While
there
many
currently
unknown
controversial
aspects
field,
we
highlight
possible
translational
practical
implications
research
advances
understanding
pathophysiology
A
better
this
issue
likely
facilitating
future
therapeutic
approaches
to
patients
based
on
medications
invasive
non-invasive
stimulation
techniques.
This
article
part
Special
Issue
"Tremor"
edited
Daniel
D.
Truong,
Mark
Hallett,
Aasef
Shaikh.
Clinical Neurophysiology Practice,
Journal Year:
2022,
Volume and Issue:
7, P. 201 - 227
Published: Jan. 1, 2022
This
review
is
part
of
the
series
on
clinical
neurophysiology
movement
disorders.
It
focuses
Parkinson’s
disease
and
parkinsonism.
The
topics
covered
include
pathophysiology
tremor,
rigidity
bradykinesia,
balance
gait
disturbance
myoclonus
in
disease.
use
electroencephalography,
electromyography,
long
latency
reflexes,
cutaneous
silent
period,
studies
cortical
excitability
with
single
paired
transcranial
magnetic
stimulation,
plasticity,
intraoperative
microelectrode
recordings
recording
local
field
potentials
from
deep
brain
electrocorticography
are
also
reviewed.
In
addition
to
advancing
knowledge
pathophysiology,
neurophysiological
can
be
useful
refining
diagnosis,
localization
surgical
targets,
help
develop
novel
therapies
for
Brain,
Journal Year:
2022,
Volume and Issue:
145(7), P. 2407 - 2421
Published: March 29, 2022
Abstract
Freezing
of
gait
is
a
debilitating
symptom
in
advanced
Parkinson’s
disease
and
responds
heterogeneously
to
treatments
such
as
deep
brain
stimulation.
Recent
studies
indicated
that
cortical
dysfunction
involved
the
development
freezing,
while
evidence
depicting
specific
role
primary
motor
cortex
multi-circuit
pathology
freezing
lacking.
Since
abnormal
beta-gamma
phase-amplitude
coupling
recorded
from
patients
with
indicates
parkinsonian
state
responses
therapeutic
stimulation,
we
hypothesized
this
metric
might
reveal
unique
information
on
understanding
improving
therapy
for
gait.
Here,
directly
potentials
using
subdural
electrocorticography
synchronously
captured
optoelectronic
motion-tracking
systems
16
freely-walking
who
received
subthalamic
nucleus
stimulation
surgery.
Overall,
451
timed
up-and-go
walking
trials
quantified
7073
s
stable
3384
conditions
on/off-stimulation
with/without
dual-tasking.
We
found
(i)
high
was
detected
(i.e.
contained
freezing),
but
not
non-freezing
trials,
caused
by
dual-tasking
or
lack
movement;
(ii)
episodes
within
also
demonstrated
abnormally
couplings,
which
predicted
severity;
(iii)
reduced
these
couplings
simultaneously
improved
freezing;
(iv)
were
at
similar
levels,
still
lower
severity
than
no-stimulation
trials.
These
findings
suggest
elevated
higher
probabilities
freezing.
Therapeutic
alleviates
both
decoupling
oscillations
enhancing
resistance
coupling.
formalized
novel
‘bandwidth
model,’
specifies
dysfunction,
cognitive
burden
emergence
By
targeting
key
elements
model,
may
develop
next-generation
approaches
Journal of Neurology,
Journal Year:
2023,
Volume and Issue:
270(11), P. 5313 - 5326
Published: Aug. 2, 2023
Abstract
Parkinson’s
disease
(PD)
is
the
second
most
common
neurodegenerative
bearing
a
severe
social
and
economic
impact.
So
far,
there
no
known
modifying
therapy
current
available
treatments
are
symptom
oriented.
Deep
Brain
Stimulation
(DBS)
established
as
an
effective
treatment
for
PD,
however
systems
lag
behind
today’s
technological
potential.
Adaptive
DBS,
where
stimulation
parameters
depend
on
patient’s
physiological
state,
emerges
important
step
towards
“smart”
strategy
that
enables
adaptive
personalized
therapy.
This
new
facilitated
by
currently
neurotechnologies
allowing
simultaneous
monitoring
of
multiple
signals,
providing
relevant
information.
Advanced
computational
models
analytical
methods
tool
to
explore
richness
data
identify
signal
properties
close
loop
in
DBS.
To
tackle
this
challenge,
machine
learning
(ML)
applied
DBS
have
gained
popularity
due
their
ability
make
good
predictions
presence
variables
subtle
patterns.
ML
based
approaches
being
explored
at
different
fronts
such
identification
electrophysiological
biomarkers
development
control
systems,
leading
relief.
In
review,
we
how
can
help
overcome
challenges
closed-loop
particularly
its
role
search
electrophysiology
biomarkers.
Promising
results
demonstrate
potential
supporting
generation
with
better
management
delivery,
resulting
more
efficient
patient-tailored
treatments.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(32)
Published: Feb. 25, 2023
Abstract
Memristive
technologies
promise
to
have
a
large
impact
on
modern
electronics,
particularly
in
the
areas
of
reconfigurable
computing
and
artificial
intelligence
(AI)
hardware.
Meanwhile,
evolution
memristive
materials
alongside
technological
progress
is
opening
application
perspectives
also
biomedical
field,
for
implantable
lab‐on‐a‐chip
devices
where
advanced
sensing
generate
amount
data.
are
emerging
as
bioelectronic
links
merging
biosensing
with
computation,
acting
physical
processors
analog
signals
or
framework
digital
architectures.
Recent
developments
processing
electrical
neural
signals,
well
transduction
chemical
biomarkers
endocrine
functions,
reviewed.
It
concluded
critical
perspective
future
applicability
pivotal
building
blocks
bio‐AI
fusion
concepts
bionic
schemes.
Frontiers in Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: Oct. 18, 2021
Adaptive
deep
brain
stimulation
(aDBS)
is
a
promising
new
technology
with
increasing
use
in
experimental
trials
to
treat
diverse
array
of
indications
such
as
movement
disorders
(Parkinson's
disease,
essential
tremor),
psychiatric
(depression,
OCD),
chronic
pain
and
epilepsy.
In
many
aDBS
trials,
neural
biomarker
interest
compared
predefined
threshold
amplitude
adjusted
accordingly.
Across
implant
locations,
potential
biomarkers
are
greatly
influenced
by
sleep.
Successful
embedded
adaptive
detectors
must
incorporate
strategy
account
for
sleep,
avoid
unwanted
or
unexpected
algorithm
behavior.
Here,
we
show
dual
design
two
independent
detectors,
one
used
track
sleep
state
(wake/sleep)
the
other
parkinsonian
motor
(medication-induced
fluctuations).
six
hemispheres
(four
patients)
47
days,
our
detector
successfully
transitioned
mode
while
patients
were
sleeping,
resumed
tracking
when
awake.
Designing
"sleep
aware"
algorithms
may
prove
crucial
deployment
clinically
effective
fully
algorithms.
Neurobiology of Disease,
Journal Year:
2022,
Volume and Issue:
168, P. 105692 - 105692
Published: March 16, 2022
Electrophysiological
biomarkers
reflecting
the
pathological
activities
in
basal
ganglia
are
essential
to
gain
an
etiological
understanding
of
Parkinson's
disease
(PD)
and
develop
a
method
diagnosing
treating
disease.
Previous
studies
that
explored
electrophysiological
PD
have
focused
mainly
on
oscillatory
or
periodic
such
as
beta
gamma
oscillations.
Emerging
evidence
has
suggested
nonoscillatory,
aperiodic
component
reflects
firing
rate
synaptic
current
changes
corresponding
cognitive
states.
Nevertheless,
it
never
been
thoroughly
examined
whether
can
be
used
biomarker
PD.
In
this
study,
we
parameters
hemiparkinsonian
rats
tested
its
practicality
activity.
We
found
set
parameters,
offset
exponent,
were
significantly
decreased
by
nigrostriatal
lesion.
To
further
prove
usefulness
biomarkers,
acute
levodopa
treatment
reverted
offset.
then
compared
with
previously
established
PD,
frequency
oscillation.
low
negative
correlation
power.
showed
performance
machine
learning-based
prediction
improved
using
both
power
component,
which
each
other.
suggest
will
provide
more
sensitive
measurement
early
diagnosis
potential
use
feedback
parameter
for
adaptive
deep
brain
stimulation.